Shulamith Rizel
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Ovarian function and disorders
Papers in
- Oncology 28
- Cancer Treatment and Pharmacology 8
- Cancer Diagnosis and Treatment 6
- HER2/EGFR in Cancer Research 4
-
- Breast Cancer Treatment Studies 18
- Co-authors
- Salomon M. Stemmer (25 shared papers)Irit Ben‐Aharon (10 shared papers)Ruth Shalgi (3 shared papers)Noa Ben-Baruch (7 shared papers)Lior Soussan‐Gutman (7 shared papers)Hadas Bar‐Joseph (2 shared papers)Rinat Yerushalmi (17 shared papers)Aarón Sulkes (17 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)PLoS ONE (4 papers)Breast Cancer Research and Treatment (3 papers)Cancer Research (3 papers)Cancer (2 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Shulamith Rizel
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 418
- Reproductive Medicine 231
- Oncology 526
- Genetics 329
- Pathology and Forensic Medicine 176
Countries citing papers authored by Shulamith Rizel
This map shows the geographic impact of Shulamith Rizel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shulamith Rizel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shulamith Rizel more than expected).
Fields of papers citing papers by Shulamith Rizel
This network shows the impact of papers produced by Shulamith Rizel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shulamith Rizel. The network helps show where Shulamith Rizel may publish in the future.
Co-authors
The 25 scholars most cited alongside Shulamith Rizel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 290 | |
| 2 | 2010 | 127 | |
| 3 | 2010 | 76 | |
| 4 | 2017 | 68 | |
| 5 | 1988 | 50 | |
| 6 | 2003 | 50 | |
| 7 | 2012 | 42 | |
| 8 | 1986 | 39 | |
| 9 | 2013 | 34 | |
| 10 | 2013 | 34 | |
| 11 | 2006 | 33 | |
| 12 | 2018 | 32 | |
| 13 | 2001 | 30 | |
| 14 | 2015 | 30 | |
| 15 | 2016 | 29 | |
| 16 | 2017 | 24 | |
| 17 | 2019 | 23 | |
| 18 | 2000 | 21 | |
| 19 | 1985 | 17 | |
| 20 | 2011 | 17 |
About Shulamith Rizel
Shulamith Rizel is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), Cancer Treatment and Pharmacology (8 papers), BRCA gene mutations in cancer (6 papers), Ovarian cancer diagnosis and treatment (6 papers), Cancer Diagnosis and Treatment (6 papers), Breast Lesions and Carcinomas (6 papers), Reproductive Biology and Fertility (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (418 citations), Reproductive Medicine (231 citations), Oncology (526 citations), Genetics (329 citations) and Pathology and Forensic Medicine (176 citations). Shulamith Rizel has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Salomon M. Stemmer, Irit Ben‐Aharon, Ruth Shalgi, Noa Ben-Baruch, Lior Soussan‐Gutman, Hadas Bar‐Joseph, Rinat Yerushalmi, Aarón Sulkes, Roman Yelensky and David Sarid. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Breast Cancer Research and Treatment, Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.